Webinar - Oncology Update - 5 August 2022
Oncology Update - Welcome & Introduction
Uncommon Mutations in mNSCLC is it correct to rely on TKY
Neoadjuvant IO in Early Lung Cancer
Evolving role of Immunotherapy in ES-SCLC
Cyramza 1stLine EGFRm+ advanced NSCLC
Optimizing Tratment for First-line NSCLC
ASCO Updates 2022 in Lung Cancer
Panel Discussion - Lessons learnt from ASCO 2022
Oncology Update Closing Remarks